Formus
Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D hip replacement surgery planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries to date. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus’s unique capabilities revolutionizes personalized orthopedics at scale to improve the outcomes of every patient.
With a successful three-year partnership in Australia and New Zealand, Formus is expanding to Japan with orthopedic market leader, Zimmer Biomet. Japan is an ideal market for Formus software, with its high adoption of CT imaging and surgical technologies. Pilots are underway with Zimmer Biomet Japan surgeons and all going well, we expect commercial launch in early 2025.
Nominated by
New Zealand Trade and Enterprise
There is widespread agreement that the process around orthopaedic surgeries remains inefficient, with poor surgical planning and execution, resulting in undesirable and unacceptable outcomes. Whilst joint implant hardware has been refined with greater precision, the analysis and planning around the selection of implant size, technological advancement around joint placement and overall pre and post-operative mechanics have been largely neglected.
The Formus solution will modernise the orthopaedics industry:
・Provides surgeons with real-time feedback from positional correlation to an implant’s expected long-term function and form.
・Ability to reduce patient wait time and time to treatment with the delivery of a clinical plan in the same day.
・Potential to improve efficiency in time for hospitals and clinicians (i.e. precise pre-operative planning that reduces intra-operative time of estimating implant size and trials).
・Allows for accurate plans to improve patient outcomes whilst still giving surgeons the flexibility and control to make decisions around the implant's fit and orientation, materially decreasing the likelihood of future revision surgeries.
・Reduction in costs by reducing the number of implants and trial trays (different sized implants) the orthopaedics companies have to ship for each surgery, which impacts inventory shipping and sterilisation costs for the hospitals.